Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Enforcement Directorate (ED)
Assam Floods
Bharat Bandh
Defence Ministry
Agnipath Scheme
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
India

DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years

DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
Written by Ramya Patelkhana
Edited by Abhishek Hari
Apr 26, 2022, 04:44 pm 3 min read
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
Two COVID-19 vaccines cleared by the DCGI for use in children between five and 12 years of age.

In a significant move, the Drugs Controller General of India (DCGI) on Tuesday cleared two COVID-19 vaccines for use in children aged between five and 12 years. The country's apex drugs regulator has granted emergency use authorization to Bharat Biotech's COVAXIN for administration to kids in the 6-12 years age group and Biological E's Corbevax for the 5-12 age group. Here are more details.

Context
Why does this story matter?
  • The development comes as India witnesses a gradual increase in COVID-19 cases, especially in Delhi, Haryana, Uttar Pradesh, Mizoram, and Maharashtra.
  • The move assumes significance as a rise in infections in children has been observed in recent weeks.
  • To recall, the Centre launched vaccinations for adolescents aged 15-18 years on January 3, 2021. Last month, the drive was expanded to children aged 12-14 years.
Details
DCGI's approval follows expert panel's recommendations

The DCGI's move comes after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) sent its recommendations to the drugs regulator, according to reports. The SEC on COVID-19 had reviewed the EUA applications submitted by Bharat Biotech and Biological E for use in 6-12 years and 5-12 years age groups, respectively, last week.

Information
Vaccines authorized for usage after severe scrutiny

The DCGI has reportedly asked Bharat Biotech to submit safety data, including information on any adverse events, with due analysis every 15 days for the initial two months. Later, the COVAXIN maker will be required to submit data on a monthly basis for five months.

COVID-19 vaccines
COVAXIN, Cobevax currently used for other age groups

To note, Bharat Biotech's COVAXIN vaccine is currently being administered in the country to adolescents aged between 15 to 18 years. It is also the first anti-COVID-19 vaccine that has been developed indigenously in India. Meanwhile, Biological E's Corbevax, which is another indigenously developed vaccine, is being provided to those between the ages of 12 and 14 at present.

New Vaccine
ZycovD vaccine also approved for those above 12

Meanwhile, Zydus Cadila's two-dose ZycovD vaccine was also approved for children over the age of 12 on Tuesday. Until Tuesday, Corbevax was the only vaccine approved for children aged 12 to 14, while Serum Institute of India's Covovax received emergency approval for the 12-17 age group. Union Health Minister Mansukh Mandaviya tweeted on Tuesday that the recent vaccine approvals have strengthened India's COVID-19 fight.

India
The current COVID-19 situation in India

India on Tuesday reported 2,483 new COVID-19 cases. The active caseload currently stands at 15,636, accounting for 0.04% of the total cases. On Tuesday, India also reported 1,399 COVID-19-related fatalities. Of these, 1,347 deaths (backlog) were reconciled by Assam, reflecting the number of COVID-19-positive patients who died due to other reasons. Meanwhile, the country's COVID-19 recovery rate stood at 98.75%.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Ramya Patelkhana
Ramya Patelkhana
Mail
Ramya Patelkhana is a senior editor at NewsBytes. She has nearly seven years of experience in digital journalism and has previously worked with India News and Authint Media. She has a Bachelor's degree in Journalism and Mass Communication from the IK Gujral Punjab Technical University, Kapurthala, and an advanced diploma in Media Studies from IPW, New Delhi.
Abhishek  Hari
Abhishek Hari
Mail
Abhishek Hari is a JRF holder in Political Science and is currently the National Writer at NewsBytes. He has previously worked as Sub-editor at The Wire and as a political researcher at the Lok Sabha Secretariat. Hindu College, University of Delhi, and Jamia Millia Islamia are his alma mater. In his free time, he loves to play the drums and listen to classic rock and roll music.
Latest
Drugs Controller General of India
COVID-19 Vaccine
COVAXIN
COVID-19 Vaccination
Corbevax
Related
Latest
'Only Murders in the Building' S2: When, where to watch?
'Only Murders in the Building' S2: When, where to watch? Entertainment
'Shaktimaan' to 'Malgudi Days': OTT platforms streaming beloved old shows
'Shaktimaan' to 'Malgudi Days': OTT platforms streaming beloved old shows Entertainment
England vs NZ, 3rd Test: Bairstow, Overton help hosts recover
England vs NZ, 3rd Test: Bairstow, Overton help hosts recover Sports
Buy the Bajaj Pulsar N160 or TVS Apache RTR 160?
Buy the Bajaj Pulsar N160 or TVS Apache RTR 160? Auto
Australia beat Sri Lanka in 5th ODI: Key stats
Australia beat Sri Lanka in 5th ODI: Key stats Sports
Drugs Controller General of India
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech India
New anti-COVID drug may cost up to Rs. 3,000: Report
New anti-COVID drug may cost up to Rs. 3,000: Report India
COVID-19 vaccine Corbevax's samples cleared by India's apex testing laboratory
COVID-19 vaccine Corbevax's samples cleared by India's apex testing laboratory India
J&J vaccine's 1cr doses ready for export after CDL nod
J&J vaccine's 1cr doses ready for export after CDL nod India
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine India
More News
COVID-19 Vaccine
No concerning trends caused by new Omicron subvariants: Experts
No concerning trends caused by new Omicron subvariants: Experts India
North Korea confirms first COVID-19 case ever, imposes nationwide lockdown
North Korea confirms first COVID-19 case ever, imposes nationwide lockdown World
COVID-19: India logs 2,927 new cases; 32 more deaths
COVID-19: India logs 2,927 new cases; 32 more deaths India
Government considering COVID-19 booster dose for all adults: Report
Government considering COVID-19 booster dose for all adults: Report India
COVID-19 vaccination for 12-14 years begins; here's how to register
COVID-19 vaccination for 12-14 years begins; here's how to register India
More News
COVAXIN
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension India
COVID-19: China fighting worst outbreak, UK sets new high
COVID-19: China fighting worst outbreak, UK sets new high World
COVAXIN supply to be increased as teens get COVID-19 vaccines
COVAXIN supply to be increased as teens get COVID-19 vaccines India
PM Modi's address: COVID-19 vaccination for 15-18-year-olds, booster doses announced
PM Modi's address: COVID-19 vaccination for 15-18-year-olds, booster doses announced India
COVAXIN found 50% effective against COVID-19 in first real-world study
COVAXIN found 50% effective against COVID-19 in first real-world study India
More News
COVID-19 Vaccination
COVID-19 vaccines prevented 42L deaths in India in 2021: Report
COVID-19 vaccines prevented 42L deaths in India in 2021: Report India
COVID-19: India logs 17,336 new cases, highest in 4 months
COVID-19: India logs 17,336 new cases, highest in 4 months India
COVID-19: India logs 13,313 fresh cases, 38 more fatalities
COVID-19: India logs 13,313 fresh cases, 38 more fatalities India
COVID-19: India logs 12,249 fresh cases, 13 more fatalities
COVID-19: India logs 12,249 fresh cases, 13 more fatalities India
COVID-19: India logs 9,923 fresh cases, 17 more fatalities
COVID-19: India logs 9,923 fresh cases, 17 more fatalities India
More News
Corbevax
Phase 2/3 trials of Corbevax on 5-18 age group permitted
Phase 2/3 trials of Corbevax on 5-18 age group permitted India
More News
Related
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
Biological E's Corbevax vaccine approved for children aged 12-18 years
Biological E's Corbevax vaccine approved for children aged 12-18 years India
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
UK to add COVAXIN to approved vaccines from November 22
UK to add COVAXIN to approved vaccines from November 22 India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022